4/21/2014 6:16:22 AM
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, will participate in RedChip’s Global Online CEO Conference on Thursday, April 24, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by